Preoperative concurrent radiotherapy with capecitabine before total mesorectal excision in locally advanced rectal cancer

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 2, 2005, Pages 346-353

  Jin, Cheon Kim ^a   Tae, Won Kim ^a   Kim, Jong Hoon ^a   Chang, Sik Yu ^a   Hee, Cheol Kim ^a   Heung, Moon Chang ^a   Min, Hee Ryu ^a   Jin, Hong Park ^a   Seung, Do Ahn ^a   Lee, Sang Wook ^a   Seong, Soo Shin ^a   Jung, Sun Kim ^a   Eun, Kyung Choi ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Capecitabine; Chemotherapy; Preoperative; Radiotherapy; Rectal cancer

Indexed keywords

CELL CULTURE; CHEMOTHERAPY; PATIENT MONITORING; TOXICITY; TUMORS;

CAPECITABINE; CHEMORADIATION (CRT); PREOPERATIVE; RECTAL CANCER;

RADIOTHERAPY;

CAPECITABINE;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ANUS; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PELVIS; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; RADIATION DERMATITIS; RADIATION DOSE; RECTUM CARCINOMA; RECTUM SURGERY; SIDE EFFECT; SPHINCTER; STANDARDIZATION; STOMATITIS; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR CELL; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS;

EID: 24944465683     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.02.046     Document Type: Article

References (36)

1. C. Camma, M. Giunta, F. Fiorica Preoperative radiotherapy for resectable rectal cancer A meta-analysis JAMA 284 2000 1008 1015
2. B. Glimelius, U. Isacsson, B. Jung Radiotherapy in addition to radical surgery in rectal cancer Evidence for a dose-response effect favoring preoperative treatment Int J Radiat Oncol Biol Phys 37 1997 281 287
3. L. Pahlman, B. Glimelius Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial Ann Surg 211 1990 187 195
4. R. Sauer, H. Becker, W. Hohenberger Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
5. J.E. Tepper, M. O'Connell, D. Niedzwiecki Adjuvant therapy in rectal cancer Analysis of stage, sex, and local control - final report of intergroup 0114 J Clin Oncol 20 2002 1744 1750
6. M.J. O'Connell, J.A. Martenson, H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502 507
7. N. Shimma, I. Umeda, M. Arasaki The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine Bioorg Med Chem 8 2000 1697 1706
8. J. Schuller, J. Cassidy, E. Dumont Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients Cancer Chemother Pharmacol 45 2000 291 297
9. T. Ishikawa, M. Utoh, N. Sawada Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts Biochem Pharmacol 55 1998 1091 1097
10. M. Miwa, M. Ura, M. Nishida Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue Eur J Cancer 34 1998 1274 1281
11. G. Liu, E. Franssen, M.I. Fitch, E. Warner Patient preferences for oral versus intravenous palliative chemotherapy J Clin Oncol 15 1997 110 115
12. N. Sawada, T. Ishikawa, F. Sekiguchi X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts Clin Cancer Res 5 1999 2948 2953
13. E. Van Cutsem, C. Twelves, J. Cassidy Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer Results of a large phase III study J Clin Oncol 19 2001 4097 4106
14. P.M. Hoff, R. Ansari, G. Batist Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer Results of a randomized phase III study J Clin Oncol 19 2001 2282 2292
15. C. Twelves Xeloda Colorectal Cancer Group Capecitabine as first-line treatment in colorectal cancer Pooled data from two large, phase III trials Eur J Cancer 38 Suppl. 2 2002 15 20
16. American Joint Committee on Cancer Cancer staging handbook 6th ed. 2001 Springer New York
17. A. Trotti, R. Byhardt, J. Stetz Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
18. J.C. Kim, K.H. Lee, C.S. Yu The clinicopathological significance of inferior mesenteric lymph node metastasis in colorectal cancer Eur J Surg Oncol 30 2004 271 279
19. J.S. Kim, J.S. Kim, M.J. Cho Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer Int J Radiat Oncol Biol Phys 54 2002 403 408
20. J. Dunst, T. Reese, T. Sutter Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer J Clin Oncol 20 2002 3983 3991
21. J.H. Lee, J.H. Lee, J.H. Ahn Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy A preliminary report J Clin Oncol 20 2002 1751 1758
22. I. Kocakova, S. Spelda, M. Svoboda Combined therapy of locally advanced rectal adenocarcinoma with capecitabine and concurrent radiotherapy [Abstract] Proc Am Soc Clin Oncol 22 2003 322
23. G.G. Shi, E. Lin, C. Eng Phase II study of capecitabine and radiotherapy (RT) plus concomitant boost in patients (pts) with locally advanced rectal cancer (LARC) [Abstract] Proc Am Soc Clin Oncol 23 2004 313
24. J. Dunst, T. Reese, J. Debus Phase II study of preoperative chemoradiation with capecitabine in rectal cancer [Abstract] Proc Am Soc Clin Oncol 23 2004 260
25. S.J. Wong, C. Sadasiwan, B. Erickson A phase II trial of pre-operative capecitabine and concurrent radiation for locally advanced rectal cancer [Abstract] Proc Am Soc Clin Oncol 23 2004 312
26. A. De Paoli, S. Chiara, G. Luppi A phase II study of capecitabine (CAP) and pre-operative radiation therapy (RT) in resectable, locally advanced rectal cancer (LARC) [Abstract] Proc Am Soc Clin Oncol 23 2004 255
27. O. Dupuis, B. Vie, G. Lledo Capecitabine (X) chemoradiation (CRT) in the perioperative treatment of patients (pts) with rectal adenocarcinomas A phase II GERCOR trial [Abstract] Proc Am Soc Clin Oncol 23 2004 255
28. D.M. Hyams, E.P. Mamounas, N. Petrelli A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum A progress report of National Surgical Adjuvant Breast and Bowel Project protocol R-03 Dis Colon Rectum 40 1997 131 139
29. J. Cassidy, W. Scheithauer, J. McKendrick Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study) Efficacy results of a phase III trial [Abstract] Proc Am Soc Clin Oncol 23 2004 14
30. C.S. Yu, J.H. Kim, J.H. Lee Efficacy of preoperative radio-chemotherapy in patients with advanced low rectal cancer J Korean Soc Coloproctol 20 2004 46 51
31. H.G. Moore, E. Riedel, B.D. Minsky Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy Ann Surg Oncol 10 2003 80 85
32. S. Andreola, E. Leo, F. Belli Adenocarcinoma of the lower third of the rectum surgically treated with a <10-mm distal clearance Preliminary results in 35 N0 patients Ann Surg Oncol 8 2001 611 615
33. P.T. Phang, J.K. MacFarlane, R.H. Taylor Effects of positive resection margin and tumor distance from anus on rectal cancer treatment outcomes Am J Surg 183 2002 504 508
34. T. Conroy, F. Bonnetain, O. Chapet Preoperative (preop) radiotherapy (RT) + 5FU/folinic acid (FA) in T3,4 rectal cancers Preliminary results of the FFCD 9203 randomized trial [Abstract] Proc Am Soc Clin Oncol 23 Suppl 2004 277
35. K. Bujko, M.P. Nowacki, A. Nasierowska-Guttmejer Sphincter preservation following preoperative radiotherapy for rectal cancer Report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15 24
36. I.C. Otto, K. Ito, C. Ye Causes of rectal incontinence after sphincter-preserving operations for rectal cancer Dis Colon Rectum 39 1996 1423 1427